Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 30.84
+0.64 (2.12%)
Jul 24, 2026, 5:29 PM CET
STO:SUS Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 67.82 | 68.88 | 144.32 | 189.15 | 162.54 | 56.52 |
Depreciation & Amortization | - | 83.37 | 60.51 | 55.61 | 51.59 | 33.52 |
Other Adjustments | -36.43 | -10.76 | -1.72 | -0.82 | -19.03 | -4.27 |
Change in Receivables | 33.01 | -87.61 | -20.24 | 31.91 | -70.76 | -84.57 |
Changes in Inventories | -3.68 | -16.39 | -11.56 | -19.57 | -21.72 | 6.46 |
Changes in Accounts Payable | -21.27 | 42.31 | -34.09 | -17.99 | 26.87 | 31.43 |
Operating Cash Flow | 150.05 | 79.8 | 137.23 | 238.29 | 129.49 | 39.08 |
Operating Cash Flow Growth | 44.58% | -41.85% | -42.41% | 84.03% | 231.31% | 68.28% |
Capital Expenditures | -18.88 | -11.68 | -6.1 | -10.46 | -9.35 | -3.87 |
Purchases of Intangible Assets | -37.71 | -37.66 | -41.43 | -33.67 | -25.2 | -10.51 |
Cash Acquisitions | -0.03 | -84.91 | - | - | - | -2,718 |
Investing Cash Flow | -56.63 | -134.25 | -47.53 | -44.13 | -34.55 | -2,733 |
Long-Term Debt Issued | -29.1 | -259.68 | 227.65 | -3.3 | 17.09 | -31.72 |
Net Long-Term Debt Issued (Repaid) | -29.1 | -259.68 | 227.65 | -3.3 | 17.09 | -31.72 |
Issuance of Common Stock | - | - | - | 19.15 | - | 3,039 |
Net Common Stock Issued (Repurchased) | - | - | - | 19.15 | - | 3,039 |
Other Financing Activities | - | - | - | - | - | -84.87 |
Financing Cash Flow | -29.11 | -259.68 | 227.65 | 15.85 | 17.09 | 2,922 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -9.5 | -37.6 | 16.44 | -9.38 | 5.02 | 0.59 |
Net Cash Flow | 64.33 | -314.13 | 317.35 | 210.01 | 112.03 | 228.93 |
Free Cash Flow | 131.16 | 68.12 | 131.12 | 227.84 | 120.14 | 35.21 |
Free Cash Flow Growth | 35.36% | -48.05% | -42.45% | 89.65% | 241.18% | 54.26% |
FCF Margin | 13.42% | 6.86% | 14.83% | 25.81% | 14.97% | 9.60% |
Free Cash Flow Per Share | 2.57 | 1.33 | 2.57 | 4.47 | 2.36 | 0.83 |
Levered Free Cash Flow | -20.73 | -95.25 | 368.06 | 238.27 | 252.45 | 122.06 |
Unlevered Free Cash Flow | 3.03 | 143.57 | 128.94 | 172.57 | 194.15 | 141.62 |